サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1159258

心臓マーカーの世界市場（2022年～2028年）

Cardiac Marker Market 2022-2028
出版日: | 発行: Orion Market Research | ページ情報: 英文 120 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円
心臓マーカーの世界市場（2022年～2028年）
出版日: 2022年09月25日
発行: Orion Market Research
ページ情報: 英文 120 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の心臓マーカーの市場規模は、予測期間中に8.9%のCAGRで拡大すると予測されています。高血圧、脂質異常症、糖尿病などの健康問題に苦しむ人々の増加が、心臓マーカー市場の成長を促進する要因となっています。

当レポートでは、世界の心臓マーカー市場について調査し、市場の概要とともに、タイプ別、用途別、検査別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

第3章 競合情勢

  • Roche Diagnostics Ltd.
  • Abbott laboratories
  • Siemens Healthineers AG
  • Danaher Corp
  • Bio merieux SA
  • 主要戦略分析
  • COVID-19が主要参入企業に与える影響

第4章 市場セグメンテーション

  • 世界の心臓マーカー市場、タイプ別
    • クレアチンキナーゼ（CK-MB）
    • トロポニン（T,I）
    • ミオグロビン
    • 虚血修飾アルブミン
    • その他
  • 世界の心臓マーカー市場、用途別
    • 心筋梗塞
    • うっ血性心不全
    • 急性冠症候群
    • アテローム性動脈硬化症
  • 世界の心臓マーカー市場、検査別
    • 検査室での検査
    • ポイントオブケア検査

第5章 地域分析

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第6章 企業プロファイル

  • LSI Medience Corporation
  • Ortho Clinical Diagnostics
  • Randox laboratories Ltd.
  • Guangzhou Wondfo Biotech Co.,Ltd
  • Diasorin S.p.A
  • Becton, Dickinson and Company
  • Bio-Rad laboratories, Inc.
  • Perkin Elmer Inc.
  • Thermo fisher scientific Inc.
  • Tosoh corporation
  • BG Medicine
  • Dia Dexus Biotechnology Co
  • Trinity Biotech
  • Thermo Fisher Scientific
  • HyTest Ltd.
図表

LIST OF TABLES

  • 1. GLOBAL CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL CREATINE KINASE CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL TROPONINS CARDIAC MARKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL MYOGLOBIN CARDIAC MARKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL ISCHEMIA MODIFIED ALBUMIN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL OTHER CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 8. GLOBAL MYOCARDIAL INFARCTION CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL CONGESTIVE HEART FAILURE CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL ACUTE CORONARY SYNDROME CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL ATHEROSCLEROSIS CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 12. GLOBAL OTHER CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 13. GLOBAL CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
  • 14. GLOBAL LABORATORY TESTING CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 15. GLOBAL POINT OF CARE TESTING MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 16. GLOBAL CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
  • 17. NORTH AMERICAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 18. NORTH AMERICAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 19. NORTH AMERICAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 20. NORTH AMERICAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
  • 21. EUROPEAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 22. EUROPEAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 23. EUROPEAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 24. EUROPEAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
  • 25. ASIA-PACIFIC CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 26. ASIA-PACIFIC CARDIAC MARKER MARKET RESEARCH AND ANALYSIS TYPE, 2021-2028 ($ MILLION)
  • 27. ASIA-PACIFIC CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 28. ASIA-PACIFIC CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
  • 29. REST OF THE WORLD CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 30. REST OF THE WORLD CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 31. REST OF THE WORLD CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 32. REST OF THE WORLD CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL CARDIAC MARKER MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL CARDIAC MARKER MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL CARDIAC MARKER MARKET, 2021-2027 (%)
  • 4. GLOBAL CARDIAC MARKER MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 5. GLOBAL CREATINE KINASE CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL TROPONINS CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL MYOGLOBIN CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 8. GLOBAL ISCHEMIA MODIFIED ALBUMIN CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL OTHER CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 10. GLOBAL CARDIAC MARKER MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
  • 11. GLOBAL MYOCARDIAL INFARCTION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL CONGESTIVE HEART FAILURE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 13. GLOBAL CORONARY SYNDROME MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 14. GLOBAL ATHEROSCLEROSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 15. GLOBAL OTHER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 16. GLOBAL CARDIAC MARKER MARKET SHARE BY LOCATION OF TESTING, 2021 VS 2028 (%)
  • 17. GLOBAL LABORATORY TESTING CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 18. GLOBAL POINT OF CARE TESTING CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 19. GLOBAL CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 20. US CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. CANADA CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. UK CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. FRANCE CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. GERMANY CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. ITALY CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. SPAIN CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. REST OF EUROPE CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. INDIA CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 29. CHINA CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 30. JAPAN CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 31. SOUTH KOREA CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 32. REST OF ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 33. REST OF THE WORLD CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
目次
Product Code: OMR2026363

Global Cardiac Marker Market Size, Share & Trends Analysis Report By Type (Creatine Kinase, Troponins, Myoglobin, Ischemia Modified Albumin, And Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, And Others), And By Location Of Testing (Laboratory Testing And Point Of Care Testing) Forecast 2022-2028

The global Cardiac Marker Market is anticipated to grow at a CAGR of 8.9% globally during the period which is taken for study. According to Food and Drug Administration is US, people who are more in weight as compared to their body mass index, were at 32% higher risk of getting infected by coronary artery disease. People who are affected by obesity when compared with people who have a normal body mass index are at a risk of 81% of getting infected by coronary artery disease. Another driver for the cardiac marker market is people globally suffering from health issues like hypertension, dyslipidemia, diabetes which further cause other health issues. Technological advancements are however making this market more flexible, and more growth can be seen with respect to testing. For instance, in May 2020, Sagentia medical, which is a research organization in the UK said that companies are working to improve the sensitivity of devices so that testing can be done on smaller samples. Abbott's i-state 1 cartridge is capable of testing cardiac markers, chemical proportion, and many other tests on one cartridge.

The global cardiac marker market is segmented based on type, application, and testing. Based on type, the market is segmented into creatine kinase, troponins, myoglobin, ischemia modified albumin, and others. Based on the application, the market is sub-segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. Based on testing, the market is sub-segmented laboratory testing and point of care testing. When we go through the segments as per the application, the acute coronary syndrome is anticipated to grow at a prominent rate in the forecasted period. This segment will see a rise as the major population is suffering from obesity and overweight issues which is the major reason for coronary syndrome. For instance, in June 2021, diagnostic company Angel medical system Inc. announced the approval of the FDA on the angel med guardian device.

Geographically market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific is going to be a prominent market for cardiac marker as with changing times, healthcare facilities in these regions are transforming rapidly. The medical sector is experiencing a continuous change through clinical laboratory technology. For instance, in Sept 2021, Biopharmaceutical company AstraZeneca has announced tying up with imperial college London startup VaxEquity to research on its Vaccine which was prepared for Coronavirus, as to how it can work on Heart disease.

The major companies serving the global cardiac marker market include Roche Diagnostics Ltd., Abbott Laboratories, Siemens Healthineers AG, Danaher Corp., Bio Merieux SA, and others. Market players are working consistently and joining hands to work in the area of cardiology. For instance, in Dec 2020, two of the prominent players in the health sector and pharmaceuticals, BridgeBio Pharma and Maze therapeutics have established a joint venture which will focus on manufacturing advanced medicines for cardiovascular disease.

 

Research Methodology

The market study of the global cardiac marker market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Cardiac marker Market Research and Analysis by Type.

2. Global Cardiac marker Market Research and Analysis by Application.

3. Global Cardiac marker Market Research and Analysis by Testing.

The Report Covers:

  • Comprehensive Research Methodology of the global cardiac marker market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global Adaptogen Market.
  • Insights about market determinants that are stimulating the global cardiac marker market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on The Global Cardiac marker Market
  • Recovery Scenario of Global Cardiac marker Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Roche Diagnostics Ltd.
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Abbott laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Siemens Healthineers AG
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Danaher Corp.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Bio merieux SA
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis
  • 3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. Global Cardiac markers Market by Type
    • 4.1.1. Creatine Kinase (CK-MB)
    • 4.1.2. Troponins (T,I)
    • 4.1.3. Myoglobin
    • 4.1.4. Ischemia Modified Albumin
    • 4.1.5. Others
  • 4.2. Global Cardiac markers Market by Application
    • 4.2.1. Myocardial Infarction
    • 4.2.2. Congestive heart failure
    • 4.2.3. Acute coronary syndrome
    • 4.2.4. Atherosclerosis
  • 4.3. Global Cardiac markers Market by Testing
    • 4.3.1. Laboratory testing
    • 4.3.2. Point of care testing

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. LSI Medience Corporation
  • 6.2. Ortho Clinical Diagnostics
  • 6.3. Randox laboratories Ltd.
  • 6.4. Guangzhou Wondfo Biotech Co.,Ltd
  • 6.5. Diasorin S.p.A
  • 6.6. Becton, Dickinson and Company
  • 6.7. Bio-Rad laboratories, Inc.
  • 6.8. Perkin Elmer Inc.
  • 6.9. Thermo fisher scientific Inc.
  • 6.10. Tosoh corporation
  • 6.11. BG Medicine
  • 6.12. Dia Dexus Biotechnology Co
  • 6.13. Trinity Biotech
  • 6.14. Thermo Fisher Scientific
  • 6.15. HyTest Ltd.